Dr. Berry completed her undergraduate education at Baylor University and holds graduate degrees from the University of Texas Health Sciences Center at Houston and the University of Washington. Her commitment to improving care of the person with cancer has spanned over three decades, beginning with her work as an oncology staff nurse and continuing with her mentorship activities and current leadership in designing, implementing, evaluating, and teaching patient-centered oncology practices. Her scholarship has been presented locally, nationally and internationally and published in nursing, medical and interdisciplinary journals, including the New England Journal of Medicine. Dr. Berry is often asked to speak and contribute in international venues, notably Australia, Switzerland, Korea, Hong Kong and Japan.
Continuously funded by NIH since 1998, Dr. Berry has pioneered in two important areas: patient-centered oncology care and nursing leadership within oncology research. To implement her patient-centered care paradigm, Dr. Berry formulated an interdisciplinary team and then led that team to successfully design and implement an accessible, computerized system to assess symptom experiences and quality of life variables. The Electronic Self report Assessment-Cancer (ESRA-C) has been found to increase patient-provider discussions of symptom and quality of life issues plus decrease symptom distress. She has led another large, multi-disciplinary team to develop, produce and test the first and only Internet intervention based on personal factors to support treatment decision-making by men with localized prostate cancer. The Personal Patient Profile-Prostate (P3P) has been shown to significantly reduce decisional conflict in men. Recognized by nomination to and election to Fellowship in the American Academy of Nursing, she has assumed increasing leadership and responsibility for transforming health care. In 2011, the Oncology Nursing Society honored Dr. Berry with the Annual Distinguished Researcher Award. The Association of Community Cancer Centers named her as the 2012 recipient of their Annual Clinical Researcher Award.
Nurse ScientistEmail: email@example.com
The focus of Dr. Cooley's work has been symptom management and quality of life in adults with cancer. She began doctoral study at University of Pennsylvania and was awarded an institutional pre-doctoral fellowship through the National Institutes for Health (NIH) and doctoral scholarships from the American Cancer Society and the Oncology Nursing Foundation. In her dissertation, Dr. Cooley described the changes in patterns of symptom distress in adults receiving treatment for lung cancer and examined the relationship of selected demographic and clinical characteristics to symptom distress over time. Results from this study found that symptom distress scores were moderate to high on entry into the study and that the change in pattern of symptom distress was not the same among treatment groups. Adults who received surgical treatment had less symptom distress at three months as compared with those who received combined treatment. Various demographic and clinical variables were weak and inconsistent predictors of symptom distress.
She then completed a post-doctoral fellowship in psychosocial oncology at University of Pennsylvania sponsored by the NIH. She conducted a secondary analysis to examine symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Results from this study found that fatigue and pain were the most distressing symptoms for each group and at each time. Significant differences in distressing symptoms among the treatment groups were noted. Many of the individual symptoms were associated with demographic and treatment group values but no consistent pattern emerged over time except for baseline symptom distress. Symptom distress at entry to the study was a strong predictor of nine distressing symptoms at three months and seven distressing symptoms at six months. Subsequently, she received funding through the American Cancer Society for a study examining the use of health status questionnaires as predictors of unscheduled health care visits in ambulatory oncology. Data analyses for this study are in the final stages. During this time, she also participated in the development of a state cancer control plan for Connecticut and as a result became interested in smoking cessation interventions.
After completing the post-doctoral fellowship, Dr. Cooley joined a multidisciplinary research team in the Smoking Cessation Research Program. While at the Smoking Cessation Research Program, Dr. Cooley was selected to attend the 2002 Summer Institute for Randomized Clinical Trials Involving Behavioral Interventions sponsored by the NIH. Most recently, Dr. Cooley was chosen as the recipient of the Oncology Nursing Society New Investigator Award. This award is presented to an investigator who is within five years of finishing his or her doctoral program and has contributed to building a scientific basis for oncology nursing. Dr. Cooley started working as a research scientist in The Phyllis F. Cantor Center for Research in Nursing and Patient Care Services in December 2002 and continues to move forward her program of research in symptom management and quality of life in adults with cancer and is beginning a program of research in smoking cessation interventions.
Dr. Underhill has focused the past 6 years of her career on understanding and improving experiences of persons with hereditary cancer risk. She received her undergraduate, graduate, and doctoral education at the University Of Buffalo School Of Nursing. Her doctoral research explored the lived experience of having hereditary breast and ovarian cancer syndrome in women with no cancer diagnosis.
She was selected as a post-doctoral research fellow through the University of Massachusetts Boston and Dana Farber Cancer Institute U54 partnership focused in cancer and health disparities, and completed this training from 2011-2013. During her fellowship Dr. Underhill completed a secondary analysis of qualitative date from women with deleterious BRCA1 or BRCA2 gene mutations, focused on exploring decision support needs. She was also funded through the Daisy Foundation to complete qualitative research focused on the meaning and experience of living with hereditary or familial pancreatic cancer.
Additionally, Meghan continues her work within the Science and Practice Aligned within Nursing initiative focused on improving patient outcomes through evidence based practice and research initiatives.
Clinical Inquiry SpecialistEmail: firstname.lastname@example.org
Jean has worked as an oncology nurse practitioner with adult cancer patients for over 18 years in clinical practice and research work. She has worked in multi-disciplinary practice teams with clinical trials work and nursing research funded work on symptom instrument development for gastrointestinal cancer patients and quality of life concerns for prostate and colorectal cancer patients/families. As a clinical inquiry specialist at DFCI, The Phyllis F. Cantor Center, Jean works with Dr. Donna Berry, Director, and a team of doctorally-prepared nurses to facilitate evidence-based practice projects with DFCI nurses. She has worked with nurse-led teams regarding oral chemotherapy adherence and symptom management of fatigue in the ambulatory setting. Current EBP work includes a project regarding preemptive dermatological management of EGFRI skin toxicity protocol to be piloted by an interdisciplinary team with lung cancer patients in DFCI Thoracic Oncology.
Clinical Inquiry SpecialistEmail: email@example.com
Kristin Roper works as a Clinical Inquiry Specialist (CIS) at the Cantor Center facilitating evidence-based practice projects with DFCI nurses. Prior to working as a CIS, Kristin worked in various positions including an inpatient oncology nurse, outpatient infusion nurse, and clinical research nurse in both medical and radiation oncology for ~25 years. Currently a PhD candidate in nursing healthcare policy at UMASS Boston, Kristin's clinical research includes health related quality of life in Hodgkin's lymphoma survivors, legislative and organizational policy initiatives relating to the HRQOL, patterns of continued employment, return to work, and work productivity of the colorectal cancer survivor. Kristin is an active member of the DFCI internal review board and the NCCN distress panel.
Post-Doctoral Research FellowEmail: firstname.lastname@example.org
Virginia LeBaron is a Post-Doctoral Research Fellow through the University of Massachusetts Boston and Dana-Farber Cancer Institute U54 Partnership in Cancer and Health Disparities. She has a PhD in Nursing from the University of Utah College of Nursing and holds advance practice certifications as an acute care nurse practitioner (ACNP-BC) and in palliative care (ACHPN) and oncology nursing (AOCN). Virginia’s developing program of research broadly focuses on how to optimize pain and symptom management for people suffering with advanced cancer. More specifically, Virginia is interested in global cancer control in lower income countries, particularly interventions to improve opioid availability and access to palliative care services that can inform policy and health care provider education. Since 2004 Virginia has served as volunteer faculty with the International Network for Cancer Treatment and Research Palliative Access Program and been involved with collaborative initiatives in India, Nepal and Tanzania. As a doctoral student, she was awarded a Fulbright-Nehru Fellowship to conduct a 9-month ethnography in South India exploring the potential relationship between opioid availability and moral distress. Virginia’s post-doctoral research through the Cantor Center will continue to seek ways to improve symptom management and palliative care for vulnerable cancer patients.
Post-Doctoral Research FellowEmail: email@example.com
Pinky H. Budhrani completed her undergraduate education at St. John's College in Belize City, Belize and the University of South Florida, Tampa. She holds graduate degrees from the University of South Florida; a Master's in Nursing with a concentration in Oncology, followed by a Ph.D. Dr. Budhrani's developing program of research focuses on integrative therapies for symptoms management; specifically sleep disturbances, fatigue, pain, depression, and anxiety in breast cancer survivors. She is interested in providing appropriate symptom management for cancer survivors in third world countries. Dr. Budhrani has been involved with collaborative initiatives in Belize City with the Belize Cancer Society. Through the Dana-Farber Cancer Institute–Phyllis F. Cantor Center Integrative Therapies Postdoctoral Fellowship, her long-term goal is to become an independent nurse scientist conducting integrative interventions to increase quality of life and decrease distress, particularly related to physical and psychological symptoms for cancer survivors both nationally and internationally.
Dr. Budhrani has participated in several national and international presentations at the Belize Cancer Society, the American Psychosocial Oncology Society, the Annual Southern Nursing Research Society Conferences, and Delta Beta Chapter of Sigma Theta Tau. Professionally, she is a member of the International Society of Delta Beta Chapter of Sigma Theta Tau in the College of Nursing, the American Nurses Association, the Oncology Nursing Society, and the American Psycho-Social Oncology Society. She has also received several awards including the Belize Cancer Society Outstanding Support Award, Sandra Holley Oncology Scholarship, Magma Cum Laude Honor Award, Clinical Excellence Award USF College of Nursing, the Latin American and Caribbean Scholarship, and recognition by USF as a member of the Honors College and Golden Key Honor Society.
Senior Clinical Research CoordinatorEmail: firstname.lastname@example.org
Erica Sorrentino works as Senior Clinical Research Coordinator in the Cantor Center on studies that primarily develop and test socio- or biobehavioral supportive care interventions for persons at risk of, receiving treatment for, or surviving cancer and their families. Erica graduated from Brandeis University in 2006 with a BA in Psychology, and continued her education at Tufts University, where she obtained her MA in Child Development, concentrating in clinical developmental psychology. In May of 2011, she completed her premedical post baccalaureate in the Health Careers Program at Harvard Extension School. Prior to joining the Cantor Center, Erica served as Project Manager for the Neurodevelopmental Disorders Phenotyping Program at Boston Children’s Hospital, whose research focus is aimed at better understanding autism spectrum disorders and other developmental disorders.
Senior Research Data SpecialistEmail: email@example.com
Erica Fox received a Bachelor of Science in Nursing from the University of Massachusetts, Boston, where she was awarded the Hebrew SeniorLife scholarship in gerontological nursing, and elected to Sigma Theta Tau International. While at the University, Erica assisted Dr. Suzanne Leveille with research exploring the efficacy of an experimental device designed to improve medication adherence in elderly patients. Erica also holds a Masters degree from Boston University in Instructional Media and Technology. Prior to joining the Cantor Center staff, Erica worked extensively in both for-profit and non-profit educational settings, as a project manager, curriculum designer and teacher. She has received numerous awards for her programs, including the Distinguished Community Service Award from Boston's Horizons for Homeless Children.
Program AdministratorEmail: firstname.lastname@example.org
As the Program Administrator for the Cantor Center, Leah handles all of the day-to-day operations of the department as well as managing all research grants and discretionary funds. She has been at Dana-Farber for eight years and has previously worked in Research Accounting and the Dana-Farber/Harvard Cancer Center. Before joining DFCI in 2005, Leah worked as a field research assistant on various projects studying the ecology of different bird species.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: